Parkwalk closes Sphere Fluidics investment for the University of Cambridge Enterprise Fund I
Sphere Fluidics has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services.
A novel technology platform (called Cyto-MineTM) enables ultra-high throughput analysis of single cells and generation of their genetic, transcriptomic and proteomic profiles in miniaturised (pl to nl) volumes called picodroplets.
